Monoclonal Antibody Development Service

About DIANA Biotechnologies

DIANA Biotechnologies is a diversified, venture-backed biotech firm leveraging its proprietary DIANA technology platform to serve the diagnostics and life science research markets. Its core business spans four segments: life science reagents (including a high-potency RNase inhibitor and reverse transcriptase), custom oligonucleotide synthesis, monoclonal antibody development, and drug discovery services like kinase inhibitor profiling. Having established itself as a major COVID-19 test producer in Czechia, the company is now targeting global expansion with its portfolio of PCR solutions and high-value research services.